Proto Labs, Inc. (NYSE:PRLB) Shares Sold by BNP Paribas Financial Markets

BNP Paribas Financial Markets trimmed its stake in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) by 65.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,908 shares of the industrial products company's stock after selling 26,152 shares during the period. BNP Paribas Financial Markets owned about 0.06% of Proto Labs worth $408,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the business. Assenagon Asset Management S.A. acquired a new stake in shares of Proto Labs during the second quarter worth $7,535,000. Bailard Inc. bought a new position in shares of Proto Labs during the second quarter worth approximately $405,000. Panagora Asset Management Inc. increased its stake in Proto Labs by 4.0% during the 2nd quarter. Panagora Asset Management Inc. now owns 168,033 shares of the industrial products company's stock worth $5,191,000 after acquiring an additional 6,469 shares during the period. Innealta Capital LLC acquired a new stake in shares of Proto Labs in the 2nd quarter valued at $40,000. Finally, Quest Partners LLC boosted its holdings in shares of Proto Labs by 146.5% in the 2nd quarter. Quest Partners LLC now owns 30,403 shares of the industrial products company's stock valued at $939,000 after purchasing an additional 18,068 shares in the last quarter. 84.54% of the stock is owned by hedge funds and other institutional investors.

Proto Labs Trading Down 1.5 %

Shares of PRLB traded down $0.67 during trading hours on Friday, reaching $43.59. 226,325 shares of the stock traded hands, compared to its average volume of 202,212. Proto Labs, Inc. has a 52-week low of $25.75 and a 52-week high of $45.15. The company's 50-day moving average price is $35.58 and its two-hundred day moving average price is $32.27. The company has a market cap of $1.07 billion, a P/E ratio of 46.37 and a beta of 1.45.

Proto Labs (NYSE:PRLB - Get Free Report) last announced its quarterly earnings results on Friday, November 1st. The industrial products company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.32 by $0.15. Proto Labs had a net margin of 4.76% and a return on equity of 3.49%. The firm had revenue of $125.60 million during the quarter, compared to analysts' expectations of $121.38 million. During the same quarter in the prior year, the company earned $0.31 EPS. The company's revenue was down 3.9% compared to the same quarter last year. On average, research analysts forecast that Proto Labs, Inc. will post 0.84 EPS for the current year.

Analyst Ratings Changes

Several research analysts have commented on PRLB shares. Needham & Company LLC reissued a "hold" rating on shares of Proto Labs in a research report on Friday, November 1st. Cantor Fitzgerald reissued an "overweight" rating and set a $40.00 target price on shares of Proto Labs in a report on Monday, November 4th. Finally, Craig Hallum increased their target price on Proto Labs from $30.00 to $36.00 and gave the company a "hold" rating in a research note on Monday, November 4th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, Proto Labs currently has an average rating of "Moderate Buy" and an average price target of $40.33.

Proto Labs Company Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.